LYB

LyondellBasell is a global commodity-chemicals producer caught in a severe cyclical downturn. FY2025 revenue fell 9.7% to $30.2B and the company swung to a net loss of -$738M from +$1.37B, driven less by operations than by $1,182M of non-cash impairments in its O&P-EAI and APS segments. Management is candid that 'petrochemical markets faced significant headwinds from global trade disruptions, falling oil prices and capacity additions which outpaced global demand growth,' compressing polyethylene and polymer chain margins. The stock at $60.07 trades for just 0.6x sales with a $19.4B market cap — pricing in the trough, not a recovery.

The quality of the loss matters. Stripping the impairments, the business still generated $2.26B of operating cash flow and returned roughly $2.0B to shareholders ($1.76B dividends plus $201M buybacks). That said, the math is tight: $2.26B operating cash flow had to cover $1.88B of capex, leaving little organic free cash to fund the dividend, which is currently being paid partly out of the balance sheet. Equity fell 19.1% to $10.1B and retained earnings dropped 26.9% to $6.81B. Management explicitly conditions future dividends on 'general business conditions, our financial condition, our earnings and cash flow' and a commitment to 'maintain an investment grade balance sheet,' which is a signal that the payout is not untouchable if the cycle stays depressed.